Catalyst Wire Dossier Catalyst Wire Dossier

Lutikizumab

lutikizumab · AbbVie
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Lutikizumab, covering 2025-01-24 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]

See pricing